QuadMedicine, Inc. (KOSDAQ:464490)
South Korea
· Delayed Price · Currency is KRW
14,010
-320 (-2.23%)
At close: Apr 28, 2026
QuadMedicine Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 |
| Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Market Capitalization | 160,864 | 176,813 | - | - |
| Enterprise Value | 140,831 | 179,911 | - | - |
| Last Close Price | 14010.00 | 15590.00 | - | - |
| PS Ratio | 15.04 | 16.53 | - | - |
| PB Ratio | 5.22 | 5.74 | - | - |
| P/TBV Ratio | 5.33 | 5.85 | - | - |
| EV/Sales Ratio | 13.16 | 16.82 | - | - |
| Debt / Equity Ratio | 0.24 | 0.24 | 0.64 | 0.72 |
| Net Debt / Equity Ratio | -0.65 | -0.65 | -0.25 | 0.22 |
| Net Debt / EBITDA Ratio | 6.49 | 6.49 | 2.24 | -0.26 |
| Net Debt / FCF Ratio | 2.97 | 2.97 | 1.31 | -0.20 |
| Asset Turnover | 0.26 | 0.26 | 0.33 | - |
| Quick Ratio | 2.75 | 2.75 | 1.80 | 1.14 |
| Current Ratio | 2.87 | 2.87 | 1.85 | 1.29 |
| Return on Equity (ROE) | -32.69% | -32.69% | -48.32% | - |
| Return on Assets (ROA) | -9.58% | -9.58% | -9.70% | - |
| Return on Capital Employed (ROCE) | -15.80% | -15.80% | -17.30% | -44.70% |
| Earnings Yield | -4.31% | -3.92% | - | - |
| FCF Yield | -4.19% | -3.81% | - | - |
| Buyback Yield / Dilution | -10.16% | -10.16% | -0.94% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.